Rapport Therapeutics, Inc. (RAPP)
Market Open
26 Oct, 06:09 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
25. 88
-0.05
-0.1928%
$
1.32B Market Cap
- P/E Ratio
- Div Yield
34,835 Volume
- Eps
$ 25.93
Previous Close 
Want to track RAPP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Rapport Therapeutics, Inc. (RAPP) Statistics
Valuation metrics
Market Cap 1.32B
Enterprise value 1.19B
Trailing P/E (ttm) -8.53
Forward P/E -
PEG ratio 0.4
Price/Sales (ttm) 62.2
Price/Book (mrq) 2.91
Enterprise Value/Revenue 59.53
Enterprise Value/EBITDA -8.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.79M
Average volume (90 days) 536.25K
Price summary
52-Week low 23.75
52-Week high 52.93
Beta -
50-Day moving average 34.75
200-Day moving average 38.88
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.86%
Operating margin -7.68%
Operational effectiveness
Return on assets -0.3%
Return on equity -0.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.42
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 15.72%
Book value per share (mrq) 8.91
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
